2010 News Releases

Keyword Search

2010 | 2009 | 2008

Date	Title
06/01/10	PIVOTAL DATA FOR THE INVESTIGATIONAL TREATMENT PSD502 FOR PRIMARY PREMATURE EJACULATION IN THE UNITED STATES TO BE PRESENTED AT MAJOR MEDICAL MEETING
05/26/10	Five Clinical Presentations Highlight Shionogi Pharma, Inc.'s PSD502, an Investigational Treatment For Primary Premature Ejaculation
04/01/10	Shionogi’s Nitrolingual® Pumpspray is Available for Angina Pectoris Patients
03/16/10	Shionogi's Third Medium-Term Business Plan
03/02/10	Shionogi Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals to Market Ospemifene
01/25/10	Shionogi Supports Efforts for Haiti Earthquake Victims
01/21/10	Shionogi Pharma Appoints Ray Russo As Vice President, Primary Care Business Unit
01/11/10	Sciele Pharma, Inc., A Shionogi Group Company, Announces Name Change
01/07/10	Sciele Introduces Adrenaclick™ (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis